What MRI findings are required according to the McDonald criteria for the diagnosis of multiple sclerosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

MRI Findings for MS Diagnosis According to McDonald Criteria

The 2024 McDonald criteria require MRI demonstration of dissemination in space (DIS) with typical lesions in at least 2 of 5 anatomical locations: periventricular (≥3 lesions), cortical/juxtacortical, infratentorial, spinal cord, and optic nerve—with MS diagnosis now possible when DIS is fulfilled even without additional dissemination in time if all other criteria are met. 1

Core Anatomical Requirements for Dissemination in Space (DIS)

The 2024 revision fundamentally expanded the anatomical framework from 4 to 5 CNS locations 1, 2:

  • Periventricular region: Requires ≥3 lesions (not just 1) 3
  • Cortical/juxtacortical lesions: Combined category including white matter adjacent to cortex and/or cortical involvement itself 3
  • Infratentorial region: Brainstem or cerebellar lesions
  • Spinal cord: Any spinal cord lesion
  • Optic nerve: Newly added fifth location, demonstrable on fat-saturated MRI sequences 1

DIS is fulfilled when typical lesions are present in at least 2 of these 5 locations. No distinction is made between symptomatic and asymptomatic lesions 3.

Dissemination in Time (DIT) Criteria

DIT can be demonstrated by:

  • Simultaneous presence of gadolinium-enhancing AND non-enhancing lesions at any time, OR
  • New T2-hyperintense or gadolinium-enhancing lesion on follow-up MRI compared to baseline, OR
  • CSF-specific oligoclonal bands or elevated kappa free light chains can substitute for DIT 2, 4

Advanced MRI Biomarkers for Diagnostic Specificity

The 2024 criteria introduce two optional high-specificity markers visible on susceptibility-sensitive sequences (T2* GRE or SWI) 1, 5:

  • Central vein sign (CVS): Demonstrates perivenular inflammation characteristic of MS
  • Paramagnetic rim lesions (PRL): Indicate chronic active lesions with iron-laden macrophages at lesion edges

These markers are particularly valuable when conventional imaging findings are insufficient or atypical, helping avoid misdiagnosis 1. They require susceptibility-weighted imaging sequences that should be incorporated when diagnostic uncertainty exists 6.

Recommended Imaging Protocol

The 2024 MAGNIMS-CMSC-NAIMS consensus specifies 1, 7:

Brain protocol:

  • Isotropic 3D FLAIR (1mm³) - essential for lesion detection
  • 3D susceptibility-sensitive sequence (T2* GRE or SWI with filtered phase) for CVS/PRL assessment
  • DWI with ADC maps
  • 3D T1-weighted post-gadolinium (at diagnosis)
  • Fat-saturated sequences for optic nerve when optic neuritis suspected

Spinal cord protocol:

  • Whole spinal cord imaging recommended (not just cervical) 3
  • At least two complementary sequences
  • High-contrast heavily T1-weighted sequence when available 7

Critical Diagnostic Pathway Changes

The 2024 criteria enable MS diagnosis in three expanded scenarios 2, 4:

  1. Classic presentations: Typical clinical attack or progression with MRI fulfilling DIS
  2. Radiologically isolated syndrome (RIS): Incidental MRI findings typical of MS can now be classified as MS when DIS and DIT criteria are met, even without clinical symptoms 1, 8
  3. Nonspecific symptoms: Patients with symptoms not clearly constituting an MS attack can fulfill criteria if imaging is typical

In the real-world German cohort, 93.5% of patients fulfilled 2024 criteria versus 84% with 2017 criteria, with optic nerve involvement accounting for 55% of additional diagnoses 8.

Special Population Considerations

Age ≥50 years and vascular comorbidities: Apply stricter diagnostic thresholds due to increased risk of misdiagnosis from vascular white matter changes 5, 4. Require more stringent evaluation of lesion morphology and distribution.

Pediatric patients ≥11 years: Use identical adult criteria for non-ADEM presentations 3

Children <11 years: Exercise caution; serial clinical and MRI evaluation over time is particularly important 3

Common Pitfalls to Avoid

  • Periventricular lesions: Must have ≥3 lesions, not just 1—this is a critical threshold change 3
  • Optic nerve assessment: Requires fat-saturated sequences; visual evoked potentials identified optic nerve lesions in 89% of cases when MRI was equivocal 8
  • CSF analysis remains essential: In the German cohort, 49% of MS diagnoses required CSF findings in addition to MRI 8
  • Atypical presentations: Always consider alternative diagnoses (NMO spectrum disorders, vasculitis, inherited leukoencephalopathies) before applying criteria 3

Practical Implementation

When conventional MRI is sufficient: 51% of patients can be diagnosed on MRI findings alone when lesions clearly fulfill DIS criteria 8

When additional testing is needed: Incorporate susceptibility-sensitive sequences for CVS/PRL, optic nerve imaging, and CSF analysis (including kappa free light chains when available) for the remaining cases with diagnostic uncertainty 1, 6

References

Related Questions

What are the 2024 McDonald criteria for diagnosing multiple sclerosis?
Can a patient experience a flare (relapse) of multiple sclerosis?
What are the diagnostic criteria for multiple sclerosis?
What is the Expanded Disability Status Scale (EDSS) and how is it used to assess disability and guide treatment in multiple sclerosis?
Can a computed tomography (CT) scan be completely normal in a patient with multiple sclerosis (MS)?
In a patient with intestinal amoebiasis presenting with loose stool and Entamoeba histolytica cysts, should metronidazole and diloxanide furoate be administered together?
What is the appropriate diagnosis and management for congenital glucose‑galactose malabsorption?
Is it safe to use a sauna one month after a superficial vein thrombosis?
What are the causes of yellow-colored urine?
What pre‑operative antibiotic prophylaxis (including drug choice, dose, timing, and adjustments for patient weight, MRSA colonization, β‑lactam allergy, and renal impairment) should be given for an orthopedic surgery?
In a patient with chronic hepatitis B and rising serum creatinine, should I switch from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF), and what is the appropriate dosing?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.